|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.19 INR | -4.77% |
|
-8.44% | -25.66% |
| 15/12 | Elitecon International Wins Over $97 Million Tobacco Supply Contract | MT |
| 15/12 | Elitecon International awarded supply contract valued at $97.35 million | RE |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -2.27 | 0.89 | -57.16 | 3.63 | 22.7 | |||||
Return on Total Capital | -2.42 | 2.2 | -406.46 | 11.4 | 35.5 | |||||
Return On Equity % | -1.29 | 12.27 | 222.66 | -6.66 | 153.2 | |||||
Return on Common Equity | -1.29 | 12.27 | 222.66 | -6.66 | 153.34 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 33.97 | 21.09 | -113.4 | 23.33 | 15.61 | |||||
SG&A Margin | 809.26 | 3.23 | 8.16 | 4.81 | 0.78 | |||||
EBITDA Margin % | - | 7.88 | -131.53 | 13.88 | 12.53 | |||||
EBITA Margin % | -1.41T | 3.25 | -134.94 | 10.51 | 12.25 | |||||
EBIT Margin % | -1.41T | 3.25 | -134.94 | 10.51 | 12.25 | |||||
Income From Continuing Operations Margin % | -445.51 | 2.25 | -134.88 | 8.41 | 12.69 | |||||
Net Income Margin % | -445.51 | 2.25 | -134.88 | 8.41 | 12.69 | |||||
Net Avail. For Common Margin % | -445.51 | 2.25 | -134.88 | 8.41 | 12.69 | |||||
Normalized Net Income Margin | -278.44 | 1.88 | -84.34 | 5.02 | 7.92 | |||||
Levered Free Cash Flow Margin | -4.06T | -147.07 | -13.72 | -141.89 | -5.81 | |||||
Unlevered Free Cash Flow Margin | -4.06T | -146.24 | -13.35 | -141.36 | -5.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0 | 0.44 | 0.68 | 0.55 | 2.97 | |||||
Fixed Assets Turnover | - | - | 6.54 | 6.13 | 45.3 | |||||
Receivables Turnover (Average Receivables) | - | - | 10.09 | 4.29 | 7.83 | |||||
Inventory Turnover (Average Inventory) | - | - | 3.99 | 1.23 | 11.41 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 13.09 | 1.51 | 0.78 | 2.47 | 2.58 | |||||
Quick Ratio | 0.11 | 0.75 | 0.23 | 1.15 | 1.94 | |||||
Operating Cash Flow to Current Liabilities | -1.82 | -0.47 | -0.3 | -1.72 | -0 | |||||
Days Sales Outstanding (Average Receivables) | - | - | 36.18 | 85.38 | 46.59 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | 91.52 | 297.8 | 31.98 | |||||
Average Days Payable Outstanding | - | - | 153.86 | 278.83 | 40.18 | |||||
Cash Conversion Cycle (Average Days) | - | - | -26.17 | 104.34 | 38.38 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 10.68 | 709.25 | -89.02 | -206.13 | 1.66 | |||||
Total Debt / Total Capital | 9.65 | 87.64 | -811.11 | 194.23 | 1.64 | |||||
LT Debt/Equity | 10.68 | 709.25 | -88.26 | -205.84 | 0.44 | |||||
Long-Term Debt / Total Capital | 9.65 | 87.64 | -804.12 | 193.96 | 0.44 | |||||
Total Liabilities / Total Assets | 14.15 | 95.31 | 186.04 | 158.24 | 36.11 | |||||
EBIT / Interest Expense | - | 2.46 | -231.41 | 12.27 | 751.73 | |||||
EBITDA / Interest Expense | - | 5.96 | -224.32 | 16.82 | 771.84 | |||||
(EBITDA - Capex) / Interest Expense | - | -16.59 | -248.33 | 16.16 | 716.71 | |||||
Total Debt / EBITDA | - | 18.54 | -0.87 | 17.47 | 0.04 | |||||
Net Debt / EBITDA | - | 18.01 | -0.86 | 17.21 | -0.08 | |||||
Total Debt / (EBITDA - Capex) | - | -6.66 | -0.79 | 18.19 | 0.04 | |||||
Net Debt / (EBITDA - Capex) | - | -6.47 | -0.78 | 17.91 | -0.09 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -95.42 | 2L | 200.26 | -1.97 | 865.72 | |||||
Gross Profit, 1 Yr. Growth % | -8.66 | 1L | -1.71T | -120.17 | 546.22 | |||||
EBITDA, 1 Yr. Growth % | - | - | -5.11T | -110.4 | 772.13 | |||||
EBITA, 1 Yr. Growth % | -0.47 | -594.34 | -12.55T | -107.64 | 1.03T | |||||
EBIT, 1 Yr. Growth % | -0.47 | -594.34 | -12.55T | -107.64 | 1.03T | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 334.16 | -1.18T | -18.11T | -106.11 | 1.36T | |||||
Net Income, 1 Yr. Growth % | 334.16 | -1.18T | -18.11T | -106.11 | 1.36T | |||||
Normalized Net Income, 1 Yr. Growth % | 334.16 | -1.55T | -13.54T | -105.84 | 1.42T | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 322.22 | -1.1T | -17.15T | -106.11 | -55.74 | |||||
Accounts Receivable, 1 Yr. Growth % | - | - | 1.67T | 43.76 | 695.9 | |||||
Inventory, 1 Yr. Growth % | - | - | 1.92 | 26.43 | 5 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | - | - | 122.29 | -48.24 | 183.1 | |||||
Total Assets, 1 Yr. Growth % | 5.79 | 2.25T | 1.71 | 38.17 | 110.59 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.28 | 28.57 | -1.96T | -6.48 | -330.89 | |||||
Common Equity, 1 Yr. Growth % | -1.28 | 28.57 | -1.96T | -6.48 | -330.89 | |||||
Cash From Operations, 1 Yr. Growth % | -224.14 | -2L | 17.64 | 172.28 | -99.97 | |||||
Capital Expenditures, 1 Yr. Growth % | - | - | 40.94 | -96.02 | 1.43T | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -290.21 | 7.67T | -72 | 914.2 | -60.45 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -290.21 | 7.62T | -72.59 | 937.96 | -60.37 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -74.44 | 891.07 | 7.93T | 71.57 | 207.69 | |||||
Gross Profit, 2 Yr. CAGR % | -25.33 | 3.39T | 14.46T | 80.47 | 14.17 | |||||
EBITDA, 2 Yr. CAGR % | - | - | - | 127.63 | -4.76 | |||||
EBITA, 2 Yr. CAGR % | 11.7 | 121.81 | 2.38T | 208.3 | -7.31 | |||||
EBIT, 2 Yr. CAGR % | 11.7 | 121.81 | 2.38T | 208.3 | -7.31 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 70.6 | 585.6 | 4.32T | 231.84 | -5.61 | |||||
Net Income, 2 Yr. CAGR % | 70.6 | 585.6 | 4.32T | 231.84 | -5.62 | |||||
Normalized Net Income, 2 Yr. CAGR % | 46.75 | 693.77 | 4.32T | 180.18 | -5.7 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 70.99 | 548.93 | 4.02T | 222.85 | -83.55 | |||||
Accounts Receivable, 2 Yr. CAGR % | - | 99.43 | - | 403.81 | 238.26 | |||||
Inventory, 2 Yr. CAGR % | - | 7.09T | - | 13.52 | 15.22 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | - | 7.26 | 21.05 | |||||
Total Assets, 2 Yr. CAGR % | 4.56 | 398.87 | 389.14 | 18.54 | 70.58 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.79 | 12.66 | 389.67 | 317.63 | 46.95 | |||||
Common Equity, 2 Yr. CAGR % | -0.79 | 12.66 | 389.67 | 317.63 | 46.95 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.03T | 866.58 | 4.38T | 78.97 | -97.02 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | - | - | -76.32 | -22.09 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 118.28 | 1.12T | 366.34 | 68.52 | 100.28 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 118.28 | 1.11T | 360.1 | 68.68 | 102.82 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -72.05 | 419.47 | 565.64 | 1.75T | 205.19 | |||||
Gross Profit, 3 Yr. CAGR % | -20.26 | 805.5 | 2.6T | 1.52T | 176.1 | |||||
EBITDA, 3 Yr. CAGR % | - | - | - | - | 256.18 | |||||
EBITA, 3 Yr. CAGR % | 5.76 | 83.39 | 749.24 | 260.85 | 374.69 | |||||
EBIT, 3 Yr. CAGR % | 5.76 | 83.39 | 749.24 | 260.85 | 374.69 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 78.69 | 215.85 | 1.94T | 392.15 | 443.39 | |||||
Net Income, 3 Yr. CAGR % | 78.69 | 215.85 | 1.94T | 392.15 | 443.36 | |||||
Normalized Net Income, 3 Yr. CAGR % | 61.1 | 214.99 | 1.94T | 384.76 | 392.6 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 78.96 | 207.8 | 1.83T | 370.21 | 66.47 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | - | 312.56 | - | 486.77 | |||||
Inventory, 3 Yr. CAGR % | - | - | 1.64T | - | 10.6 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | - | 48.23 | |||||
Total Assets, 3 Yr. CAGR % | 3.81 | 195.17 | 193.61 | 220.94 | 43.57 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.38 | 8.17 | 187.12 | 181.99 | 242.76 | |||||
Common Equity, 3 Yr. CAGR % | -0.38 | 8.17 | 187.12 | 181.99 | 242.76 | |||||
Cash From Operations, 3 Yr. CAGR % | -1.55 | 3.15T | 379 | 1.66T | -89.85 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | - | - | - | -5.07 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 11.1 | 617.92 | 245.84 | 504.19 | 3.95 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 10.95 | 616.57 | 242.75 | 503.43 | 4.08 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -60.85 | 113.82 | 168.92 | 233.51 | 388.86 | |||||
Gross Profit, 5 Yr. CAGR % | -58.45 | 224.69 | 541.93 | 375 | 661.44 | |||||
EBITA, 5 Yr. CAGR % | 22.44 | 34.55 | 273.6 | 125.74 | 250.14 | |||||
EBIT, 5 Yr. CAGR % | 22.44 | 34.55 | 273.6 | 125.74 | 250.14 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 6.83 | 55.19 | 544.55 | 222.15 | 496.34 | |||||
Net Income, 5 Yr. CAGR % | 6.83 | 55.19 | 544.55 | 222.15 | 496.32 | |||||
Normalized Net Income, 5 Yr. CAGR % | -3.83 | 53.15 | 505.75 | 200.58 | 496.18 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 7.35 | 53.14 | 527.71 | 213.73 | 186.87 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | -10.12 | - | - | 281.06 | |||||
Inventory, 5 Yr. CAGR % | - | - | - | - | 487.41 | |||||
Total Assets, 5 Yr. CAGR % | -2.89 | 84.93 | 92.98 | 104.92 | 136.28 | |||||
Tangible Book Value, 5 Yr. CAGR % | 0.15 | 4.96 | 88.35 | 85.68 | 119.64 | |||||
Common Equity, 5 Yr. CAGR % | 0.13 | 4.96 | 88.35 | 85.68 | 119.64 | |||||
Cash From Operations, 5 Yr. CAGR % | 24.8 | 129.95 | 142.85 | 918.33 | -37.18 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -6.36 | 159.01 | 97.2 | 302.08 | 177.96 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -6.36 | 158.65 | 95.98 | 301.77 | 177.86 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















